AS 1949490Selective SHIP2 inhibitor CAS# 1203680-76-5 |
- L-690,488
Catalog No.:BCC5667
CAS No.:142523-14-6
- L-690,330
Catalog No.:BCC5666
CAS No.:142523-38-4
- D-myo-Inositol-1,3,4,5-tetrakisphosphate, octapotassium salt
Catalog No.:BCC7058
CAS No.:145843-69-2
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 1203680-76-5 | SDF | Download SDF |
PubChem ID | 44473434 | Appearance | Powder |
Formula | C20H18ClNO2S | M.Wt | 371.88 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 100 mM in DMSO and to 100 mM in ethanol | ||
Chemical Name | 3-[(4-chlorophenyl)methoxy]-N-[(1S)-1-phenylethyl]thiophene-2-carboxamide | ||
SMILES | CC(C1=CC=CC=C1)NC(=O)C2=C(C=CS2)OCC3=CC=C(C=C3)Cl | ||
Standard InChIKey | RFZPGNRLOKVZJY-AWEZNQCLSA-N | ||
Standard InChI | InChI=1S/C20H18ClNO2S/c1-14(16-5-3-2-4-6-16)22-20(23)19-18(11-12-25-19)24-13-15-7-9-17(21)10-8-15/h2-12,14H,13H2,1H3,(H,22,23)/t14-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Selective SHIP2 (SH2 domain-containing inositol 5'-phosphatase 2) inhibitor (IC50 values are 0.34 μM and 0.62 μM for mouse and human respectively); displays approximately 30-fold affinity for SHIP2 over SHIP1. Increases insulin-induced phosphorylation of Akt in L6 myotubules. Stimulates activation of glucose metabolism; regulates gluconeogenesis in vitro and in vivo and exhibits antidiabetic effects. |
AS 1949490 Dilution Calculator
AS 1949490 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.689 mL | 13.4452 mL | 26.8904 mL | 53.7808 mL | 67.226 mL |
5 mM | 0.5378 mL | 2.689 mL | 5.3781 mL | 10.7562 mL | 13.4452 mL |
10 mM | 0.2689 mL | 1.3445 mL | 2.689 mL | 5.3781 mL | 6.7226 mL |
50 mM | 0.0538 mL | 0.2689 mL | 0.5378 mL | 1.0756 mL | 1.3445 mL |
100 mM | 0.0269 mL | 0.1345 mL | 0.2689 mL | 0.5378 mL | 0.6723 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
AS 1949490 is a selective inhibitor of Src homology 2 domain-containing inositol-5-phosphatase 2 (SHIP2), [1] with IC50 values of 0.34 µM and 0.62 µM to mouse and human SHIP2s, respectively [2].
SHIP2 is an intracellular phosphatase and appears to be important in insulin signaling as a negative regulator. SHIP2 has potential to act as a treatment for type 2 diabetes because of its inhibition [2].
Akt is a key enzyme to regulated insulin signaling. AS 1949490 treatment dose-dependently increased insulin-induced phosphorylation of Akt in L6 myotubes, but did not result in any associated changes in the overall level of Akt protein and the fetal bovine serum-induced phosphorylation of Akt. Treatments with AS 1949490 at several concentrations of and 1 nM insulin for 48 h, showed more consumption of glucose in the medium in a concentration-dependent manner [2].
In diabetic db/db mice, administered with AS 1949490 twice daily p.o. for 7 or 10 days significantly decreased plasma glucose (23% reduction, relative to vehicle), without affecting insulin levels, food intake or body weight. In the 10th day, treatment with AS 1949490 resulted in significant reduction in both the area under the blood glucose concentration time curve (AUC) and fasting blood glucose (37% reduction, compared with vehicle; time = -30 min) [2].
References:
[1]. Laura Beth J. McIntire, Kyu-In Lee, Belle Chang-IIeto, et al. Screening assay for small molecule inhibitors of synaptojanin 1, a synaptic phosphoinositide phosphatase. J Biomol Screen, 2014, 19(4):585-594.
[2]. A Suwa, T Yamamoto, A Sawada, et al. Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2. British Journal of Pharmacology, 2009, 158:879-887.
- Cyclotraxin B
Catalog No.:BCC6357
CAS No.:1203586-72-4
- DASA-58
Catalog No.:BCC6522
CAS No.:1203494-49-8
- Citroside A
Catalog No.:BCN7294
CAS No.:120330-44-1
- CX-6258
Catalog No.:BCC1504
CAS No.:1202916-90-2
- Dorzolamide
Catalog No.:BCC4287
CAS No.:120279-96-1
- 4-Hydroxysapriparaquinone
Catalog No.:BCN4806
CAS No.:120278-25-3
- Salvinolone
Catalog No.:BCN3215
CAS No.:120278-22-0
- CNX-774
Catalog No.:BCC4394
CAS No.:1202759-32-7
- AVL-292
Catalog No.:BCC1385
CAS No.:1202757-89-8
- CGS 21680
Catalog No.:BCC1475
CAS No.:120225-54-9
- 1beta-Hydroxyeuscaphic acid
Catalog No.:BCN3517
CAS No.:120211-98-5
- Tenidap
Catalog No.:BCC7419
CAS No.:120210-48-2
- Jionoside B1
Catalog No.:BCN2858
CAS No.:120406-37-3
- Biapenem
Catalog No.:BCC1071
CAS No.:120410-24-4
- AZD1208
Catalog No.:BCC2079
CAS No.:1204144-28-4
- Icotinib Hydrochloride
Catalog No.:BCC1639
CAS No.:1204313-51-8
- TMC647055
Catalog No.:BCC6376
CAS No.:1204416-97-6
- Verlukast
Catalog No.:BCC2035
CAS No.:120443-16-5
- Jionoside A1
Catalog No.:BCN2922
CAS No.:120444-60-2
- (±)-Vesamicol hydrochloride
Catalog No.:BCC6737
CAS No.:120447-62-3
- ER 27319 maleate
Catalog No.:BCC5914
CAS No.:1204480-26-1
- Lophanthoidin B
Catalog No.:BCN6091
CAS No.:120462-42-2
- Lophanthoidin E
Catalog No.:BCN6092
CAS No.:120462-45-5
- Lophanthoidin F
Catalog No.:BCN6093
CAS No.:120462-46-6
Glucose metabolism activation by SHIP2 inhibitors via up-regulation of GLUT1 gene in L6 myotubes.[Pubmed:20558154]
Eur J Pharmacol. 2010 Sep 10;642(1-3):177-82.
Lipid phosphatase SH2 domain-containing inositol 5'-phosphatase 2 (SHIP2) plays an important role in the regulation of insulin signaling. In this report, we identified AS1938909, a novel small-molecule SHIP2 inhibitor. AS1938909 showed potent inhibition of SHIP2 (Ki=0.44 microuM) and significant selectivity over other related phosphatases. Further, AS1938909 increased Akt phosphorylation, glucose consumption, and glucose uptake in L6 myotubes. Treatment of L6 myotubes with SHIP2 inhibitors for 48 h significantly induced expression of GLUT1 mRNA, but not that of GLUT4. These results suggest that pharmacological inhibition of SHIP2 activates glucose metabolism due, at least in part, to up-regulation of GLUT1 gene expression.